Variant-selective stereopure oligonucleotides protect against pathologies associated with C9orf72-repeat expansion in preclinical models

C9orf72 expansion mutations are the most common genetic cause of ALS and FTD, which have limited therapies. The authors generate stereopure oligonucleotides that selectively deplete expansion-containing transcripts and protect against expansion-associated pathologies in preclinical models.

Guardado en:
Detalles Bibliográficos
Autores principales: Yuanjing Liu, Jean-Cosme Dodart, Helene Tran, Shaunna Berkovitch, Maurine Braun, Michael Byrne, Ann F. Durbin, Xiao Shelley Hu, Naoki Iwamoto, Hyun Gyung Jang, Pachamuthu Kandasamy, Fangjun Liu, Kenneth Longo, Jörg Ruschel, Juili Shelke, Hailin Yang, Yuan Yin, Amy Donner, Zhong Zhong, Chandra Vargeese, Robert H. Brown
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Q
Acceso en línea:https://doaj.org/article/c67a2cf526554819ac5be15eaecb07de
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c67a2cf526554819ac5be15eaecb07de
record_format dspace
spelling oai:doaj.org-article:c67a2cf526554819ac5be15eaecb07de2021-12-02T14:26:59ZVariant-selective stereopure oligonucleotides protect against pathologies associated with C9orf72-repeat expansion in preclinical models10.1038/s41467-021-21112-82041-1723https://doaj.org/article/c67a2cf526554819ac5be15eaecb07de2021-02-01T00:00:00Zhttps://doi.org/10.1038/s41467-021-21112-8https://doaj.org/toc/2041-1723C9orf72 expansion mutations are the most common genetic cause of ALS and FTD, which have limited therapies. The authors generate stereopure oligonucleotides that selectively deplete expansion-containing transcripts and protect against expansion-associated pathologies in preclinical models.Yuanjing LiuJean-Cosme DodartHelene TranShaunna BerkovitchMaurine BraunMichael ByrneAnn F. DurbinXiao Shelley HuNaoki IwamotoHyun Gyung JangPachamuthu KandasamyFangjun LiuKenneth LongoJörg RuschelJuili ShelkeHailin YangYuan YinAmy DonnerZhong ZhongChandra VargeeseRobert H. BrownNature PortfolioarticleScienceQENNature Communications, Vol 12, Iss 1, Pp 1-15 (2021)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Yuanjing Liu
Jean-Cosme Dodart
Helene Tran
Shaunna Berkovitch
Maurine Braun
Michael Byrne
Ann F. Durbin
Xiao Shelley Hu
Naoki Iwamoto
Hyun Gyung Jang
Pachamuthu Kandasamy
Fangjun Liu
Kenneth Longo
Jörg Ruschel
Juili Shelke
Hailin Yang
Yuan Yin
Amy Donner
Zhong Zhong
Chandra Vargeese
Robert H. Brown
Variant-selective stereopure oligonucleotides protect against pathologies associated with C9orf72-repeat expansion in preclinical models
description C9orf72 expansion mutations are the most common genetic cause of ALS and FTD, which have limited therapies. The authors generate stereopure oligonucleotides that selectively deplete expansion-containing transcripts and protect against expansion-associated pathologies in preclinical models.
format article
author Yuanjing Liu
Jean-Cosme Dodart
Helene Tran
Shaunna Berkovitch
Maurine Braun
Michael Byrne
Ann F. Durbin
Xiao Shelley Hu
Naoki Iwamoto
Hyun Gyung Jang
Pachamuthu Kandasamy
Fangjun Liu
Kenneth Longo
Jörg Ruschel
Juili Shelke
Hailin Yang
Yuan Yin
Amy Donner
Zhong Zhong
Chandra Vargeese
Robert H. Brown
author_facet Yuanjing Liu
Jean-Cosme Dodart
Helene Tran
Shaunna Berkovitch
Maurine Braun
Michael Byrne
Ann F. Durbin
Xiao Shelley Hu
Naoki Iwamoto
Hyun Gyung Jang
Pachamuthu Kandasamy
Fangjun Liu
Kenneth Longo
Jörg Ruschel
Juili Shelke
Hailin Yang
Yuan Yin
Amy Donner
Zhong Zhong
Chandra Vargeese
Robert H. Brown
author_sort Yuanjing Liu
title Variant-selective stereopure oligonucleotides protect against pathologies associated with C9orf72-repeat expansion in preclinical models
title_short Variant-selective stereopure oligonucleotides protect against pathologies associated with C9orf72-repeat expansion in preclinical models
title_full Variant-selective stereopure oligonucleotides protect against pathologies associated with C9orf72-repeat expansion in preclinical models
title_fullStr Variant-selective stereopure oligonucleotides protect against pathologies associated with C9orf72-repeat expansion in preclinical models
title_full_unstemmed Variant-selective stereopure oligonucleotides protect against pathologies associated with C9orf72-repeat expansion in preclinical models
title_sort variant-selective stereopure oligonucleotides protect against pathologies associated with c9orf72-repeat expansion in preclinical models
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/c67a2cf526554819ac5be15eaecb07de
work_keys_str_mv AT yuanjingliu variantselectivestereopureoligonucleotidesprotectagainstpathologiesassociatedwithc9orf72repeatexpansioninpreclinicalmodels
AT jeancosmedodart variantselectivestereopureoligonucleotidesprotectagainstpathologiesassociatedwithc9orf72repeatexpansioninpreclinicalmodels
AT helenetran variantselectivestereopureoligonucleotidesprotectagainstpathologiesassociatedwithc9orf72repeatexpansioninpreclinicalmodels
AT shaunnaberkovitch variantselectivestereopureoligonucleotidesprotectagainstpathologiesassociatedwithc9orf72repeatexpansioninpreclinicalmodels
AT maurinebraun variantselectivestereopureoligonucleotidesprotectagainstpathologiesassociatedwithc9orf72repeatexpansioninpreclinicalmodels
AT michaelbyrne variantselectivestereopureoligonucleotidesprotectagainstpathologiesassociatedwithc9orf72repeatexpansioninpreclinicalmodels
AT annfdurbin variantselectivestereopureoligonucleotidesprotectagainstpathologiesassociatedwithc9orf72repeatexpansioninpreclinicalmodels
AT xiaoshelleyhu variantselectivestereopureoligonucleotidesprotectagainstpathologiesassociatedwithc9orf72repeatexpansioninpreclinicalmodels
AT naokiiwamoto variantselectivestereopureoligonucleotidesprotectagainstpathologiesassociatedwithc9orf72repeatexpansioninpreclinicalmodels
AT hyungyungjang variantselectivestereopureoligonucleotidesprotectagainstpathologiesassociatedwithc9orf72repeatexpansioninpreclinicalmodels
AT pachamuthukandasamy variantselectivestereopureoligonucleotidesprotectagainstpathologiesassociatedwithc9orf72repeatexpansioninpreclinicalmodels
AT fangjunliu variantselectivestereopureoligonucleotidesprotectagainstpathologiesassociatedwithc9orf72repeatexpansioninpreclinicalmodels
AT kennethlongo variantselectivestereopureoligonucleotidesprotectagainstpathologiesassociatedwithc9orf72repeatexpansioninpreclinicalmodels
AT jorgruschel variantselectivestereopureoligonucleotidesprotectagainstpathologiesassociatedwithc9orf72repeatexpansioninpreclinicalmodels
AT juilishelke variantselectivestereopureoligonucleotidesprotectagainstpathologiesassociatedwithc9orf72repeatexpansioninpreclinicalmodels
AT hailinyang variantselectivestereopureoligonucleotidesprotectagainstpathologiesassociatedwithc9orf72repeatexpansioninpreclinicalmodels
AT yuanyin variantselectivestereopureoligonucleotidesprotectagainstpathologiesassociatedwithc9orf72repeatexpansioninpreclinicalmodels
AT amydonner variantselectivestereopureoligonucleotidesprotectagainstpathologiesassociatedwithc9orf72repeatexpansioninpreclinicalmodels
AT zhongzhong variantselectivestereopureoligonucleotidesprotectagainstpathologiesassociatedwithc9orf72repeatexpansioninpreclinicalmodels
AT chandravargeese variantselectivestereopureoligonucleotidesprotectagainstpathologiesassociatedwithc9orf72repeatexpansioninpreclinicalmodels
AT roberthbrown variantselectivestereopureoligonucleotidesprotectagainstpathologiesassociatedwithc9orf72repeatexpansioninpreclinicalmodels
_version_ 1718391337393324032